1-Aryl-2-aminoimidazolines were used to synthesize many chain and fused imidazolidine derivatives exhibiting pharmacological activity. Compounds bearing the 1-aryl substituent were found to possess significant central activity, especially antinociceptive and serotonergic. 1-4 Further, the 1aromatic substituent was found to be a pharmacophoric group both for the opioid MOP (mu opioid peptide) receptor and the 5-HT2 (serotonin type 2) receptor affinity of the imidazoline derivatives. 2,3 Among the aryl substituents, the 4-chlorophenyl one, due to its higher lipophilicity, plays an important role. Usually, the 4-chlophenyl derivatives were the most active. In some cases they were even responsible for the selectivity of the action. 4 The title 1-(4-chloropheny)-2-aminoimidazoline-2 was synthesized from N-(4-chlorophenyl)-1,2-diaminoethane and cyanogen bromide and a further transformation of its hydrobromide into the free base by action of sodium hydroxide and extraction with methylene chloride. In order to establish the tautomerization ratio of the quanidine fragment in the investigated molecule (Scheme I) and to make a comparison of its geometry with that observed for protonated quanidine, 5 an Xray analysis was undertaken.
1-Aryl-2-aminoimidazolines were used to synthesize many chain and fused imidazolidine derivatives exhibiting pharmacological activity. Compounds bearing the 1-aryl substituent were found to possess significant central activity, especially antinociceptive and serotonergic. [1] [2] [3] [4] Further, the 1aromatic substituent was found to be a pharmacophoric group both for the opioid MOP (mu opioid peptide) receptor and the 5-HT2 (serotonin type 2) receptor affinity of the imidazoline derivatives. 2, 3 Among the aryl substituents, the 4-chlorophenyl one, due to its higher lipophilicity, plays an important role. Usually, the 4-chlophenyl derivatives were the most active. In some cases they were even responsible for the selectivity of the action. 4 The title 1-(4-chloropheny)-2-aminoimidazoline-2 was synthesized from N-(4-chlorophenyl)-1,2-diaminoethane and cyanogen bromide and a further transformation of its hydrobromide into the free base by action of sodium hydroxide and extraction with methylene chloride. In order to establish the tautomerization ratio of the quanidine fragment in the investigated molecule (Scheme I) and to make a comparison of its geometry with that observed for protonated quanidine, 5 an Xray analysis was undertaken.
A solution of N-(4-chlorophenyl)-1,2-diaminoethane (0.1 mol) in 100 ml of 2-propanol was added drop-wise into a solution of cyanogen bromide (0.1 mol) in 150 ml of 2-propanol. The mixture was stirred for 4 h at room temperature, and then under reflux for an additional 4 h. The mixture was kept overnight, precipitation separated and purified by crystallization from a methanol-2-propanol (1:2) mixture.
1-(4-Chloropheny)-2aminoimidazoline-2 hydrobromide was solved in 100 ml of water, 10 g of solid sodium hydroxide was added and extraction with 3 × 50 ml of methylene chloride was performed. The solvent was removed and the residue crystallized from Colorless prismatic crystals suitable for X-ray diffraction analysis were grown by the slow evaporation of a toluene solution.
X-ray data were collected by graphitemonochromatized Cu Kα radiation at 293 K, ω-2θ scans. The structure was solved by direct methods and refined by the full- matrix least-squares method with anisotropic temperature factors for non-H atoms. All hydrogen atoms were located from a ∆ρ map, and their coordinates were refined with isotropic displacement parameters taken as 1.5-times those of the respective parent atoms. Details of the crystal data and a structure refinement and selected geometrical parameters are given in Tables 1, 2 and 3 . A view of the molecule with numbering of the atoms is shown in Fig. 1 .
The difference electron density map for the investigated compound revealed the position of the H atoms in the vicinity of the N6 atom. Additionally, the differentiation of the C-N bond lengths in the quanidine part of the molecule was observed: N1-C2 = 1.394(2)Å, N3-C2 = 1.317(3)Å and N6-C2 = 1.328(2)Å. These two facts indicate that the amino tautomeric form presented in Scheme I is the one existing in the crystalline state. However, in the crystalline state, inversionrelated molecules form dimmers via the strong intermolecular hydrogen bond, N6-H61·N3 (i) [N6-H61 = 0.88(3), H61·N3 = 2.01(3), N6·N3 = 2.885(3)Å, N6-H61·N3 = 174(3)˚ and (i) = -x + 2, -y, -z + 1]. The presence of that hydrogen bond can suggest a slight delocalization of the amino hydrogen into the imino form in the guanidine moiety. The partially saturated imidazoline ring adopts a half-chair conformation with opposite displacements of the C4 and C5 atoms from the ring plane defined by the three N1-C2-N3 atoms of the guanidine moiety location of this ring by -0.123(2) and 0.305(2)Å, respectively. The orientation of the phenyl substituent in relation to the heterocyclic system is described by a torsion angle (C2-N1-C11-C12) of -46.0(2)˚. 
